Table 3.

The Characteristics of the Subjects

Variable	PCOS		Control (n = 76)
	IR (n = 96)	Non-IR (n = 72)
Age (years)	31.5 ± 8.6a	31.5 ± 9.2b	35.6 ± 8.6
BMI (kg/m2)	26.7 ± 1.9a,c	22.8 ± 2.0	21.4 ± 1.8
Waist-hip ratio (WHR)	0.91 ± 0.13a,c	0.86 ± 0.12	0.85 ± 0.12
Systolic pressure (mmHg)	120.1 ± 15.3a,c	109 ± 10.2	104 ± 11.7
Diastolic pressure (mmHg)	76 ± 8.2a	74 ± 5.8b	71.1 ± 4.5
Fasting blood glucose (mmol/L)	5.41 ± 0.73a,c	4.45 ± 0.56	4.27 ± 0.48
Fasting insulin (mU/L)	22.75 ± 4.90a,c	11.49 ± 2.15b	9.13 ± 1.38
HOMA-IR	5.37 ± 0.82a,c	2.23 ± 0.25b	1.73 ± 0.32
High-density lipoprotein (mmol/L)	1.29 ± 0.18a	1.34 ± 0.31	1.42 ± 0.24
Low-density lipoprotein (mmol/L)	2.10 ± 0.57a	2.34 ± 0.51	2.49 ± 0.38
Triglyceride (mmol/L)	2.14 ± 0.31a,c	1.18 ± 0.22	0.89 ± 0.14
Free testosterone	4.1 ± 1.2a,c	2.6 ± 0.7b	1.3 ± 0.2
Total testosterone (ng/mL)	0.97 ± 0.13a,c	0.72 ± 0.08b	0.51 ± 0.09
Ovarian volume (cm3)	11.32 ± 1.64	10.76 ± 0.87	6.76 ± 0.52

PCOS, polycystic ovary syndrome; IR, insulin resistance; HOMA-IR, homeostasis model assessment for insulin resistance.

^ap < 0.05, the IR group versus the control group

^bp < 0.05, the non-IR group versus the control group

^cp < 0.05, the IR group versus the non-IR group.